现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • MSC2360844 hemifumarate
MSC2360844 hemifumarate的可视化放大

MSC2360844 hemifumarate

MSC2360844hemifumarate是一种有效的,具有口服活性的选择性PI3Kδ抑制剂,IC50为145nM。MSC2360844hemifumarate对一组278种其他激酶显示出高度选择性。

原价
¥3262-25112
价格
2610-20090
MSC2360844 hemifumarate的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajcx31124
  • CAS: 1621688-31-0
  • 别名: MSC2360844 hemifumarate; IOA-244 hemifumarate
  • 分子式: C26H27FN4O5S.1/2C4H4O4
  • 分子量: 584.62
  • 纯度: >98%
  • 溶解度:
  • 储存: Store at -20°C
  • 库存: 现货

Background

MSC2360844 hemifumarate is a potent, orally active and selective PI3Kδ inhibitor, with an IC50 of 145 nM. MSC2360844 hemifumarate shows highly selective against a panel of 278 additional kinases[1].


MSC2360844 hemifumarate (0-10 μM; 1 hours) completely abolished BCR-induced pAkt in Ramos B cells in a concentration-dependent manner with IC50 values of 280 nM[1]. MSC2360844 hemifumarate inhibits B cell proliferation in a concentration-dependent manner with an IC50 of 48 nM. MSC2360844 hemifumarate blocks BCR- and TCR-mediated responses in lymphocytes and TLR-induced IFNα by pDC in human primary cells[1]. Cell Viability Assay[1] Cell Line: B cells


MSC2360844 hemifumarate (6.6-66 mg/kg; daily from week 2 to 10) ameliorates disease manifestations in a murine SLE model[1]. Animal Model: NZB/W F1 female mice[1]


[1]. Haselmayer P, et al. Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies. Front Immunol. 2014 May 22;5:233.

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服